GlassScriptPhysician profile
Ahmad Musa
NPI 1144840661
$2,481.60
in general payments reported to CMS, 2019-2025
17 companies · $415 in 2025
The $415 reported for 2025 was more than what 81% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.58 · 2023: $1,957 · 2024: $30.94 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,546 · Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,546.26 |
| Food and Beverage | $856.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Uk Limited | $1,909.86 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $192.74 | 2023-2025 | Breztri, Farxiga |
| Dexcom, INC. | $106.46 | 2025 | Dexcom G6 Transmitter |
| Smith+Nephew, INC. | $51.64 | 2022 | |
| Glaxosmithkline, LLC. | $33.82 | 2023-2025 | Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $26.94 | 2022 | |
| Globus Medical, INC. | $24.06 | 2025 | Senza |
| Genzyme Corporation | $21.99 | 2025 | |
| Paratek Pharmaceuticals, INC. | $18.48 | 2025 | Nuzyra |
| Inspire Medical Systems, INC. | $16.66 | 2025 | Inspire |
| Amgen INC. | $16.59 | 2023 | Repatha, Otezla |
| Pfizer INC. | $16.58 | 2024 | |
| Merck Sharp & Dohme LLC | $15.88 | 2025 | Capvaxive, Gardasil 9 |
| Exact Sciences Corporation | $15.54 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $14.36 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Musa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.